Japan Genome Editing Market (2025 - 2033) Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9), By Delivery Method (Ex Vivo), By Application (Genetic Engineering, Clinical Applications), By Mode (Contract, In-house), By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                        1.2.1. Technology Segment
                        1.2.2. Method Segment
                        1.2.3. Application Segment
                        1.2.4. Mode Segment
                        1.2.5. End-use Segment
                    1.3. Information analysis
                    1.4. Market formulation & data visualization
                    1.5. Data validation & publishing
                    1.6. Information Procurement
                        1.6.1. Primary Research
                    1.7. Information or Data Analysis
                    1.8. Market Formulation & Validation
                    1.9. Market Model
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. Japan Genome Editing Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                        3.3.2. PESTEL Analysis
                        3.3.3. COVID-19 Impact Analysis
Chapter 4. Japan Genome Editing Market: Technology Business Analysis
                    4.1. Technology Segment Dashboard
                    4.2. Japan Genome Editing Market Technology Movement Analysis
                    4.3. Japan Genome Editing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
                    4.4. CRISPR/Cas9
                        4.4.1. CRISPR/Cas9 market estimates and forecasts 2021 to 2033 (USD Million)
                    4.5. TALENs/MegaTALs
                        4.5.1. TALENS/MegaTALs market estimates and forecasts 2021 to 2033 (USD Million)
                    4.6. ZFN
                        4.6.1. ZFN market estimates and forecasts 2021 to 2033 (USD Million)
                    4.7. Meganucleases
                        4.7.1. Meganucleases market estimates and forecasts 2021 to 2033 (USD Million)
                    4.8. Others
                        4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Japan Genome Editing Market: Delivery Method Business Analysis
                    5.1. Delivery Method Segment Dashboard
                    5.2. Japan Genome Editing Market Delivery Method Movement Analysis
                    5.3. Japan Genome Editing Market Size & Trend Analysis, by Delivery Method, 2021 to 2033 (USD Million)
                    5.4. Ex-vivo
                        5.4.1. Ex-vivo market estimates and forecasts 2021 to 2033 (USD Million)
                    5.5. In- vivo
                        5.5.1. In-Vivo market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Japan Genome Editing Market: Application Business Analysis
                    6.1. Application Segment Dashboard
                    6.2. Japan Genome Editing Market Application Movement Analysis
                    6.3. Japan Genome Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    6.4. Genetic Engineering
                        6.4.1. Genetic Engineering market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.2. Cell line engineering
                            6.4.2.1. Cell line engineering market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.3. Animal genetic engineering
                            6.4.3.1. Animal genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.4. Plant genetic engineering
                            6.4.4.1. Plant genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
                        6.4.5. Others
                            6.4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
                    6.5. Clinical Applications
                        6.5.1. Clinical Applications market estimates and forecasts 2021 to 2033 (USD Million)
                        6.5.2. Therapy Development
                            6.5.2.1. Therapy Development market estimates and forecasts 2021 to 2033 (USD Million)
                        6.5.3. Diagnostics Development
                            6.5.3.1. Diagnostics Development market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Japan Genome Editing Market: Mode Business Analysis
                    7.1. Mode Segment Dashboard
                    7.2. Japan Genome Editing Market Mode Movement Analysis
                    7.3. Japan Genome Editing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
                    7.4. Contract
                        7.4.1. Contract market estimates and forecasts 2021 to 2033 (USD Million)
                    7.5. In- house
                        7.5.1. In-house market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Japan Genome Editing Market: End Use Estimates & Trend Analysis
                    8.1. End Use Segment Dashboard
                    8.2. Japan Genome Editing Market End Use Movement Analysis
                    8.3. Japan Genome Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    8.4. Biotechnology & Pharmaceutical Companies
                        8.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
                    8.5. Academic & Research Institutes
                        8.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
                    8.6. Contract Research Organizations
                        8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Company/Competition Categorization
                    9.2. Strategy Mapping
                    9.3. Company Market Position Analysis, 2024
                    9.4. Company Profiles/Listing
                        9.4.1. Merck KGaA
                            9.4.1.1. Company overview
                            9.4.1.2. Financial performance
                            9.4.1.3. Product benchmarking
                            9.4.1.4. Strategic initiatives
                        9.4.2. Takara Bio Inc.
                            9.4.2.1. Company overview
                            9.4.2.2. Financial performance
                            9.4.2.3. Product benchmarking
                            9.4.2.4. Strategic initiatives
                        9.4.3. Revvity, Inc.
                            9.4.3.1. Company overview
                            9.4.3.2. Financial performance
                            9.4.3.3. Product benchmarking
                            9.4.3.4. Strategic initiatives
                        9.4.4. Danaher Corporation
                            9.4.4.1. Company overview
                            9.4.4.2. Financial performance
                            9.4.4.3. Product benchmarking
                            9.4.4.4. Strategic initiatives
                        9.4.5. GenScript
                            9.4.5.1. Company overview
                            9.4.5.2. Financial performance
                            9.4.5.3. Product benchmarking
                            9.4.5.4. Strategic initiatives
                        9.4.6. New England Biolabs
                            9.4.6.1. Company overview
                            9.4.6.2. Financial performance
                            9.4.6.3. Product benchmarking
                            9.4.6.4. Strategic initiatives
                        9.4.7. Lonza
                            9.4.7.1. Company overview
                            9.4.7.2. Financial performance
                            9.4.7.3. Product benchmarking
                            9.4.7.4. Strategic initiatives
                        9.4.8. Thermo Fisher Scientific, Inc.
                            9.4.8.1. Company overview
                            9.4.8.2. Financial performance
                            9.4.8.3. Product benchmarking
                            9.4.8.4. Strategic initiatives
                        9.4.9. Charles River Laboratories
                            9.4.9.1. Company overview
                            9.4.9.2. Financial performance
                            9.4.9.3. Product benchmarking
                            9.4.9.4. Strategic initiatives
                        9.4.10. Eurofins Scientific
                            9.4.10.1. Company overview
                            9.4.10.2. Financial performance
                            9.4.10.3. Product benchmarking
                            9.4.10.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Japan Genome editing Market, By technology, 2021 - 2033 (USD Million)
Table 5 Japan Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
Table 6 Japan Genome editing Market, By application, 2021 - 2033 (USD Million)
Table 7 Japan Genome editing Market, By mode, 2021 - 2033 (USD Million)
Table 8 Japan Genome editing Market, By end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Japan genome editing market segmentation
Fig. 2 Information procurement
Fig. 3 Data analysis models
Fig. 4 Market formulation and validation
Fig. 5 Data validating & publishing
Fig. 6 Market research process
Fig. 7 Information procurement
Fig. 8 Primary research
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Japan genome editing market: Technology outlook key takeaways
Fig. 13 Japan genome editing market: Technology movement analysis
Fig. 14 Japan CRISPR/Cas9 market, 2021 - 2033 (USD Million)
Fig. 15 Japan TALENs/MegaTALs market, 2021 - 2033 (USD Million)
Fig. 16 Japan ZFN market, 2021 - 2033 (USD Million)
Fig. 17 Japan meganucleases market, 2021 - 2033 (USD Million)
Fig. 18 Japan others market, 2021 - 2033 (USD Million)
Fig. 19 Japan genome editing market: Delivery Method outlook and key takeaways
Fig. 20 Japan genome editing market: Delivery Method movement analysis
Fig. 21 Japan ex- vivo market, 2021 - 2033 (USD Million)
Fig. 22 Japan in- vivo market, 2021 - 2033 (USD Million)
Fig. 23 Japan genome editing market: Application outlook and key takeaways
Fig. 24 Japan genome editing market: Application movement analysis
Fig. 25 Japan genetic engineering market, 2021 - 2033 (USD Million)
Fig. 26 Japan cell line engineering market, 2021 - 2033 (USD Million)
Fig. 27 Japan animal engineering market, 2021 - 2033 (USD Million)
Fig. 28 Japan plant engineering market, 2021 - 2033 (USD Million)
Fig. 29 Japan others market, 2021 - 2033 (USD Million)
Fig. 30 Japan clinical applications market, 2021 - 2033 (USD Million)
Fig. 31 Japan diagnostics development market, 2021 - 2033 (USD Million)
Fig. 32 Japan therapy development market, 2021 - 2033 (USD Million)
Fig. 33 Japan genome editing market: Mode outlook and key takeaways
Fig. 34 Japan genome editing market: Mode movement analysis
Fig. 35 Japan contract market, 2021 - 2033 (USD Million)
Fig. 36 Japan in- house market, 2021 - 2033 (USD Million)
Fig. 37 Japan genome editing market: End use outlook and key takeaways
Fig. 38 Japan genome editing market: End use movement analysis
Fig. 39 Japan biotechnology & pharmaceutical companies market, 2021 - 2033 (USD Million)
Fig. 40 Japan academic & research institutes market, 2021 - 2033 (USD Million)
Fig. 41 Japan contract research organizations market, 2021 - 2033 (USD Million)